Raicher Irina, Caramelli Paulo
Division of Neurology of the Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.
Behavioral and Cognitive Neurology Research Group, Department of Internal Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Dement Neuropsychol. 2008 Oct-Dec;2(4):267-271. doi: 10.1590/S1980-57642009DN20400006.
Although growing, the literature on research into attitudes of general and specialized physicians towards disclosing the diagnosis of dementia and Alzheimer's disease (AD), or the current practice on AD disclosure, remains limited. Moreover, information is also scarce on what caregivers, or indeed patients themselves, wish to know with regard to their diagnosis. The goal of the present article was to present a review of the current available literature on the topic of truth telling in dementia, especially in AD. The studies discussed in this review were mainly conducted in Europe, particularly in the United Kingdom, as well as the United States. Disclosure of AD diagnosis is not a common practice among physicians. In the clinical context, the discussion on diagnosis disclosure can be valuable for improving the care of AD patients and their families.
尽管相关研究在不断增加，但关于普通医生和专科医生对披露痴呆症和阿尔茨海默病（AD）诊断的态度的文献，或当前关于AD诊断披露的实践，仍然有限。此外，关于护理人员或患者自身希望了解哪些有关其诊断信息的内容也很匮乏。本文的目的是对当前关于痴呆症，尤其是AD中告知真相这一主题的现有文献进行综述。本综述中讨论的研究主要在欧洲进行，特别是在英国，以及美国。向患者披露AD诊断在医生中并非普遍做法。在临床环境中，关于诊断披露的讨论对于改善AD患者及其家人的护理可能具有重要价值。
